等待开盘 05-21 09:30:00 美东时间
+0.595
+5.23%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $30 to $13.
05-07 03:26
华盛资讯5月6日讯,窥得儿医药公布2026财年Q1业绩,公司Q1营收6.20亿美元,同比下降10.5%,归母净利润亏损0.92亿美元,同比亏损扩大622.8%。
05-06 18:19
华盛资讯5月6日讯,窥得儿医药公布2026财年Q1业绩,公司Q1营收6.20亿美元,同比下降10.5%,归母净利润亏损0.92亿美元,同比亏损扩大622.8%。
05-06 08:42
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
SAN DIEGO, April 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 57 of its Science Bytes podcast, focusing on e...
04-23 21:32
– Marks a Milestone in QuidelOrtho's Plans to Accelerate Growth in Point-of-Care Molecular Diagnostics – – Expands Portfolio with Ultra-Fast PCR Platform Designed to Deliver Results in Appro...
04-20 19:12
QuidelOrtho (QDEL) stock hits 52-week low as Q1 revenue of $615M-$620M misses targets. China snags and a weak flu season drive 32% decline.
04-17 01:45
QDEL stock drops in after-hours trading on Wednesday as QuidelOrtho reports weak Q1 revenue outlook and expects negative near-term cash flow.
04-16 14:41